Company research
Heartflow, Inc.
CIK 1464521Updated Sep 24, 2026
SecurityHTFL · NASDAQ · equity
Name history
Cardiovascular Simulation, Inc. · through Jun 14, 2010
HTFL price & chart
Loading TradingView…
NASDAQ:HTFL on TradingView ↗About the company
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,800 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 625 peer-reviewed publications, Heartflow has redefined how clinicians manage care for more than 750,000 patients worldwide. 1 Key benefits include:
In the news
The Future of Intoxication Detection May Be in Your Voice ↗
Bain Capital sells $58.9 million of Heartflow (NASDAQ:HTFL) stock ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 359,452,000Source | 118,704,000Source |
| Property, Plant and Equipment, NetUSD | 8,587,000Source | 8,920,000Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 44,776,000Source | 51,367,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 29,343,000Source | 24,639,000Source |
| Assets, CurrentUSD | 220,204,000Source | 82,288,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 14,075,000Source | 6,132,000Source |
| Operating Lease, Right-of-Use AssetUSD | 17,488,000Source | 18,805,000Source |
| Other Assets, NoncurrentUSD | 5,099,000Source | 4,366,000Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 58,805,000Source | 209,622,000Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 85,000Source | 6,000Source |
| Additional Paid in CapitalUSD | 1,388,737,000Source | 112,241,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,087,750,000Source | -970,959,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -425,000Source | -772,000Source |
| Stockholders' Equity Attributable to ParentUSD | 300,647,000Source | -859,484,000Source |
| Liabilities and EquityUSD | 359,452,000Source | 118,704,000Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 42,370,000Source | 33,605,000Source |
| Operating Lease, Liability, CurrentUSD | 5,922,000Source | 5,416,000Source |
| Accounts Payable, CurrentUSD | 3,169,000Source | 2,870,000Source |
| Operating Lease, Liability, NoncurrentUSD | 16,132,000Source | 18,537,000Source |
| Other Liabilities, NoncurrentUSD | 303,000Source | 214,000Source |
| Additional Financial Items | ||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 280,200,000Source | — |
| Short-term InvestmentsUSD | 132,010,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash flows from operating activities: | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation, Depletion and AmortizationUSD | 5,440,000Source | 5,358,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 13,965,000Source | 10,213,000Source |
| Changes in operating assets and liabilities: | ||
| Increase (Decrease) in Accounts ReceivableUSD | 4,892,000Source | 3,849,000Source |
| Increase (Decrease) in Accounts PayableUSD | 218,000Source | -327,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -54,023,000Source | -69,001,000Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -238,568,000Source | -4,357,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 5,025,000Source | 4,357,000Source |
| Cash flows from financing activities: | ||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 510,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 286,043,000Source | 2,237,000Source |
| Repayments of Long-term DebtUSD | 115,137,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -6,357,000Source | -71,392,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 49,485,000Source | 55,842,000Source |
| Supplemental disclosure of cash flow information: | ||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 8,573,000Source | 19,163,000Source |
| Additional Financial Items | ||
| Share-based Payment Arrangement, ExpenseUSD | 13,965,000Source | 10,213,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 5,367,000Source | 1,609,000Source |
| Capitalized Computer Software, AmortizationUSD | 4,000,000Source | 3,700,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 280,200,000Source | — |
| Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously RecordedUSD | 0Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | -6,360,000Source | — |
| General and Administrative ExpenseUSD | 39,490,000Source | 30,789,000Source |
| Income Tax Expense (Benefit)USD | -76,000Source | 53,000Source |
| InterestExpenseNonoperatingUSD | 15,173,000Source | 22,768,000Source |
| Investment Income, InterestUSD | 5,538,000Source | 4,066,000Source |
| Net Income (Loss) Attributable to ParentUSD | -116,791,000Source | -96,426,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -116,791,000Source | -96,426,000Source |
| Nonoperating Income (Expense)USD | -52,801,000Source | -35,151,000Source |
| Operating ExpensesUSD | 199,263,000Source | 155,671,000Source |
| Other Nonoperating Income (Expense)USD | -223,000Source | 168,000Source |
| Payments to Acquire InvestmentsUSD | 233,543,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 3,298,000Source | 4,564,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | 7,311,000Source | -222,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Total RevenueUSD | 176,034,000Source | 125,808,000Source |
| Cost of Goods and Services Sold | — | — |
| Selling, General and Administrative ExpenseUSD | 134,345,000Source | 112,154,000Source |
| Operating Income (Loss)USD | -64,066,000Source | -61,222,000Source |
| Other Nonoperating Income (Expense)USD | -223,000Source | 168,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -116,867,000Source | -96,373,000Source |
| Income Tax Expense (Benefit)USD | -76,000Source | 53,000Source |
| Net Income (Loss) Attributable to ParentUSD | -116,791,000Source | -96,426,000Source |
| Earnings Per Share, BasicUSD per share | -3.17Source | -17.98Source |
| Earnings Per Share, DilutedUSD per share | -3.17Source | -17.98Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 36,853,867Source | 5,363,435Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 36,853,867Source | 5,363,435Source |
| Interest Expense (non-operating)USD | 15,173,000Source | 22,768,000Source |
| Additional Financial Items | ||
| Capitalized Computer Software, AmortizationUSD | 4,000,000Source | 3,700,000Source |
| General and Administrative ExpenseUSD | 39,490,000Source | 30,789,000Source |
| Gross ProfitUSD | 135,197,000Source | 94,449,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -110,784,000Source | -96,422,000Source |
| Investment Income, InterestUSD | 5,538,000Source | 4,066,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -116,791,000Source | -96,426,000Source |
| Nonoperating Income (Expense)USD | -52,801,000Source | -35,151,000Source |
| Operating ExpensesUSD | 199,263,000Source | 155,671,000Source |
| Research and Development ExpenseUSD | 64,918,000Source | 43,517,000Source |
| Selling ExpenseUSD | 75,709,000Source | 66,895,000Source |
Offerings
Registration 333-288733
- Deal price
- 19.0
- Offering price
- $19.00
- Ticker
- HTFL
Filing attachments
htfl-20260813xex99_1.htm · 8-K · 2026-08-13
EX-99.1 2 htfl-20260813xex99_1.htm EX-99.1 Exhibit 991 20260813 Exhibit 99.1 Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance SAN FRANCISCO - August 13, 2026 - Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights Total revenue of $64.1 million, a 48% increase year-over-y…
Read attachment ↗htfl-20260514xex99_1.htm · 8-K · 2026-05-14
EX-99.1 2 htfl-20260514xex99_1.htm EX-99.1 Exhibit 99.1 2026.05.14 Exhibit 99.1 Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance SAN FRANCISCO - May 14, 2026 - Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Total revenue of $52.6 million, a 41% increase year-over-year Gross …
Read attachment ↗htfl-20260318xex99_1.htm · 8-K · 2026-03-18
EX-99.1 2 htfl-20260318xex99_1.htm EX-99.1 Exhibit 99.1 2026.03.18 Exhibit 99.1 Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results MOUNTAIN VIEW, Calif. - March 18, 2026 - Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Highlights Total revenue of $49.1 million, a 40% increase year-over-ye…
Read attachment ↗htfl-20260112xex99_1.htm · 8-K · 2026-01-12
EX-99.1 2 htfl-20260112xex99_1.htm EX-99.1 Exhibit 991 Exhibit 99.1 Heartflow Investor Presentation January 2026 Disclaimers Forward-Looking Statements This presentation includes express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this presentation, including statements regarding our strategy, futu…
Read attachment ↗